Stallion India Fluorochemicals Ltd
₹ 197
-0.98%
19 Sep
- close price
About
Incorporated in 2002, Stallion India Fluorochemicals Limited is engaged in selling Refrigerant and Industrial Gases and related products.[1]
Key Points
- Market Cap ₹ 1,560 Cr.
- Current Price ₹ 197
- High / Low ₹ 217 / 59.9
- Stock P/E 45.5
- Book Value ₹ 37.9
- Dividend Yield 0.00 %
- ROCE 19.7 %
- ROE 15.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 134 days to 193 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|
118 | 186 | 226 | 233 | 377 | 415 | |
104 | 153 | 208 | 209 | 330 | 365 | |
Operating Profit | 14 | 33 | 18 | 24 | 48 | 49 |
OPM % | 12% | 18% | 8% | 10% | 13% | 12% |
1 | 0 | -2 | 3 | 2 | 2 | |
Interest | 0 | 1 | 1 | 4 | 6 | 5 |
Depreciation | 1 | 2 | 2 | 1 | 1 | 1 |
Profit before tax | 13 | 30 | 13 | 22 | 42 | 45 |
Tax % | 27% | 30% | 25% | 28% | 24% | |
10 | 21 | 10 | 15 | 32 | 34 | |
EPS in Rs | 8.04 | 17.23 | 1.77 | 2.52 | 4.08 | 4.71 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 27% |
TTM: | 62% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 15% |
TTM: | 109% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 16% |
Last Year: | 15% |
Balance Sheet
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Equity Capital | 12 | 12 | 55 | 61 | 79 |
Reserves | 28 | 49 | 16 | 64 | 222 |
10 | 2 | 18 | 65 | 2 | |
104 | 35 | 37 | 9 | 30 | |
Total Liabilities | 153 | 98 | 126 | 200 | 334 |
19 | 18 | 13 | 14 | 17 | |
CWIP | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 |
134 | 80 | 113 | 186 | 316 | |
Total Assets | 153 | 98 | 126 | 200 | 334 |
Cash Flows
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
-8 | 8 | -3 | -73 | -13 | |
-2 | -1 | -13 | 12 | -20 | |
12 | -8 | 16 | 76 | 76 | |
Net Cash Flow | 2 | -1 | -1 | 15 | 43 |
Ratios
Figures in Rs. Crores
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Debtor Days | 282 | 56 | 69 | 111 | 102 |
Inventory Days | 128 | 113 | 80 | 178 | 128 |
Days Payable | 394 | 76 | 46 | 7 | 27 |
Cash Conversion Cycle | 16 | 93 | 103 | 282 | 203 |
Working Capital Days | 57 | 82 | 62 | 147 | 193 |
ROCE % | 55% | 22% | 18% | 20% |
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 16 Sep
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
15 Sep - AGM 15 Sep 2025; proposed equity/equity-linked fundraising, ESOP 2025 approval, director appointments.
-
Intimation Regarding Allotment Of Land Received For Our Manufacturing Plant At Bhilwara, Rajasthan
29 Aug - 29 Aug 2025: Received RIICO land allotment for Bhilwara manufacturing plant; registration and possession formalities initiated.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 Aug - Newspaper Advertisement for 23rd Annual General Meeting of the Company.
- Notice Of 23Rd Annual General Meeting Of The Company To Be Held On 15Th September, 2025. 24 Aug
Concalls
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT REC
Business Overview[1]
Stallion India Fluorochemicals Limited specializes in manufacturing and distributing refrigerants and specialty gases. With nearly two decades of expertise, the company blends Hydrofluorocarbons (HFCs) and Hydrofluoroolefins (HFOs) for applications across industries such as semiconductors, automotive, electronics, pharmaceuticals, fire extinguishment systems, and aerosol production.